Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives
暂无分享,去创建一个
[1] D. Milardi,et al. Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. , 2015, European journal of medicinal chemistry.
[2] J. Brender,et al. Probing the sources of the apparent irreproducibility of amyloid formation: drastic changes in kinetics and a switch in mechanism due to micellelike oligomer formation at critical concentrations of IAPP. , 2015, The journal of physical chemistry. B.
[3] A. Miranker,et al. Peptide Amyloid Surface Display , 2014, Biochemistry.
[4] S. Radford,et al. Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions , 2014, Biochemistry.
[5] S. Radford,et al. Screening and classifying small molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry , 2014, Nature Chemistry.
[6] A. Miranker,et al. Fiber-dependent and -independent toxicity of islet amyloid polypeptide. , 2014, Biophysical journal.
[7] W. V. Van Nostrand,et al. Capping of Aβ42 Oligomers by Small Molecule Inhibitors , 2014, Biochemistry.
[8] J. Brender,et al. Interaction and reactivity of synthetic aminoisoflavones with metal-free and metal-associated amyloid-β , 2014 .
[9] 임미희. Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-b Species , 2014 .
[10] A. Miranker,et al. Small molecule screening in context: Lipid‐catalyzed amyloid formation , 2014, Protein science : a publication of the Protein Society.
[11] D. Raleigh,et al. General Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers , 2014, PloS one.
[12] Suresh Govindaraghavan,et al. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective. , 2014, CNS & neurological disorders drug targets.
[13] A. Miranker,et al. Folded small molecule manipulation of islet amyloid polypeptide. , 2014, Chemistry & biology.
[14] A. Ramamoorthy,et al. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study. , 2014, Biochemical and biophysical research communications.
[15] Huanxiang Liu,et al. Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1–37) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation , 2014, PloS one.
[16] Jie Zheng,et al. Non-selective ion channel activity of polymorphic human islet amyloid polypeptide (amylin) double channels. , 2014, Physical chemistry chemical physics : PCCP.
[17] J. Fantini,et al. Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. , 2014, ACS chemical neuroscience.
[18] Sanghyun Lee,et al. Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. , 2014, Journal of the American Chemical Society.
[19] S. Radford,et al. Ion Mobility Spectrometry–Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors , 2013, Journal of the American Chemical Society.
[20] Ishita Guha Thakurta,et al. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants. , 2013, Current medicinal chemistry.
[21] S. Radford,et al. Aggregation modulators interfere with membrane interactions of β2-microglobulin fibrils. , 2013, Biophysical journal.
[22] E. Karnaukhova,et al. Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity. , 2013, Physical chemistry chemical physics : PCCP.
[23] M. Stefani,et al. Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds , 2013, International journal of molecular sciences.
[24] J. Kelly,et al. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. , 2013, Journal of the American Chemical Society.
[25] A. Miranker,et al. A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide. , 2013, Chemical communications.
[26] Hong Chen,et al. Salvianolic acid B inhibits the amyloid formation of human islet amyloid polypeptideand protects pancreatic beta‐cells against cytotoxicity , 2013, Proteins.
[27] A. Miranker,et al. Common mechanism unites membrane poration by amyloid and antimicrobial peptides , 2013, Proceedings of the National Academy of Sciences.
[28] N. Kotov,et al. Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. , 2013, Biochemistry.
[29] J. Brender,et al. Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-β species , 2013, Proceedings of the National Academy of Sciences.
[30] J. Brender,et al. Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. , 2013, Biophysical journal.
[31] E. Wanker,et al. Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? , 2013, EPMA Journal.
[32] S. Radford,et al. Direct three-dimensional visualization of membrane disruption by amyloid fibrils , 2012, Proceedings of the National Academy of Sciences.
[33] J. Brender,et al. Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. , 2012, Biochemistry.
[34] Ayyalusamy Ramamoorthy,et al. Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. , 2012, Biochemistry.
[35] Michael H. Hecht,et al. A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation , 2012, The Journal of Biological Chemistry.
[36] J. Gaines,et al. Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance. , 2012, ACS medicinal chemistry letters.
[37] Maarten F. M. Engel,et al. The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution. , 2012, Journal of the American Chemical Society.
[38] U. Fink,et al. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. , 2012, Journal of molecular biology.
[39] Ayyalusamy Ramamoorthy,et al. Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. , 2012, Biophysical journal.
[40] D. Moffet,et al. Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity , 2012, The open biochemistry journal.
[41] Samuel Sparks,et al. Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. , 2012, Biochemical and biophysical research communications.
[42] J. Brender,et al. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). , 2012, The journal of physical chemistry. B.
[43] D. Raleigh,et al. Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. , 2012, Biochemistry.
[44] D. Raleigh,et al. Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers , 2012, Protein science : a publication of the Protein Society.
[45] A. Naito,et al. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. , 2012, Journal of molecular biology.
[46] Shirley Y. Lee,et al. A partially folded structure of amyloid-beta(1-40) in an aqueous environment. , 2011, Biochemical and biophysical research communications.
[47] Per Westermark,et al. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. , 2011, Physiological reviews.
[48] Hexafluoroisopropanol Induces Amyloid Fibrils of Islet Amyloid Polypeptide by Enhancing Both Hydrophobic and Electrostatic Interactions* , 2011, The Journal of Biological Chemistry.
[49] J. Brender,et al. The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. , 2011, Biochimica et biophysica acta.
[50] Joan-Emma Shea,et al. Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27. , 2011, Biophysical journal.
[51] J. Brender,et al. Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. , 2011, Biophysical journal.
[52] P. Magistretti,et al. Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species* , 2010, The Journal of Biological Chemistry.
[53] Yuguang Mu,et al. The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide* , 2010, The Journal of Biological Chemistry.
[54] M. Hecht,et al. Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. , 2010, Journal of the American Chemical Society.
[55] Fanling Meng,et al. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. , 2010, Biochemistry.
[56] H. Guy,et al. Polyhistidine peptide inhibitor of the Abeta calcium channel potently blocks the Abeta-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process. , 2010, Biochemistry.
[57] J. Brender,et al. Role of zinc in human islet amyloid polypeptide aggregation. , 2010, Journal of the American Chemical Society.
[58] M. Biancalana,et al. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.
[59] H. Guy,et al. Polyhistidine Peptide Inhibitor of the Aβ Calcium Channel Potently Blocks the Aβ-Induced Calcium Response in Cells , 2010 .
[60] J. Hofrichter,et al. Evidence for a partially structured state of the amylin monomer. , 2009, Biophysical journal.
[61] Tak W. Kee,et al. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds , 2009, The FEBS journal.
[62] Roland Winter,et al. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. , 2009, Journal of the American Chemical Society.
[63] N. Opitz,et al. Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol , 2009, FEBS letters.
[64] J. Brender,et al. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.
[65] Felipe Garcia Quiroz,et al. Amyloid-β-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy , 2009, Neurotoxicity Research.
[66] K. Jacobson,et al. Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity , 2009, Proceedings of the National Academy of Sciences.
[67] Roland Winter,et al. Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol , 2009, Chembiochem : a European journal of chemical biology.
[68] Gerard J A Kroon,et al. Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. , 2008, Biochemistry.
[69] Rebecca Deprez-Poulain,et al. Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery , 2008, Chemical biology & drug design.
[70] D. Ehrnhoefer,et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.
[71] D. Raleigh,et al. Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death. , 2008, Biochemistry.
[72] Maarten F. M. Engel,et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.
[73] J. Brender,et al. Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. , 2007, Biochimica et biophysica acta.
[74] J. Díaz,et al. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers , 2007 .
[75] N. Fullwood,et al. Copper‐mediated formation of hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cells in type‐2 diabetes mellitus? , 2007, FEBS letters.
[76] Andrew D. Miranker,et al. Direct detection of transient α‐helical states in islet amyloid polypeptide , 2007 .
[77] R. Hepler,et al. Solution State Characterization of Amyloid β-Derived Diffusible Ligands , 2006 .
[78] Dong Jin Kim,et al. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. , 2006, ACS chemical biology.
[79] Ehud Gazit,et al. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.
[80] H. Lashuel. Membrane permeabilization: a common mechanism in protein-misfolding diseases. , 2005, Science of aging knowledge environment : SAGE KE.
[81] Hai Lin,et al. Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[82] A. Gee,et al. Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils* , 2005, Journal of Biological Chemistry.
[83] E. Wilander,et al. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus , 1978, Diabetologia.
[84] Kate A. Stafford,et al. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[85] U. Aebi,et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.
[86] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[87] E. Rhoades,et al. Micelle formation by a fragment of human islet amyloid polypeptide. , 2003, Biophysical journal.
[88] Y. Surh,et al. Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .
[89] Y. Surh,et al. Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. , 2003, Free radical biology & medicine.
[90] A. Miranker,et al. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. , 2002, Biochemistry.
[91] S. Woods,et al. Amylin: a novel action in the brain to reduce body weight. , 2000, Endocrinology.
[92] M. Delepierre,et al. The “Pre-Molten Globule,” a New Intermediate in Protein Folding , 1997, Journal of protein chemistry.
[93] B. Kagan,et al. Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.
[94] E. Kandel,et al. Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[95] R. Holman,et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.
[96] C. Wernstedt,et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. , 1986, Biochemical and biophysical research communications.
[97] J. Hutton. The internal pH and membrane potential of the insulin-secretory granule. , 1982, The Biochemical journal.
[98] E. Opie. ON THE RELATION OF CHRONIC INTERSTITIAL PANCREATITIS TO THE ISLANDS OF LANGERHANS AND TO DIABETES MELUTUS , 1901, The Journal of experimental medicine.